assembly biosciences stock forecast

Assembly Biosciences, Inc. is a biotechnology company. SOUTH SAN FRANCISCO, Calif., May 06, 2021 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV), today reported financial results and recent updates for the first quarter ended March 31, 2021. The largest stake in Assembly Biosciences Inc (NASDAQ:ASMB) was held by Consonance Capital Management, which reported holding $47.1 million worth of stock at the end of September. During the last session, Assembly Biosciences, Inc. (NASDAQ:ASMB)’s traded shares were 923,844, with the beta value of the company hitting 0.34. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Get the latest Price and Consensus Chart for Assembly Biosciences, Inc. from Zacks Investment Research The stock options were granted as material inducements to the new employees to accept the Company’s offers of employment. This suggests a possible upside of 177.1% from the stock's current price. SOUTH SAN FRANCISCO, Calif., May 06, 2021 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV), today reported financial results and recent updates for the first quarter ended March 31, 2021. The highest, average, and lowest price target of all analysts. Assembly Biosciences stock price target cut to $13 from $30 at Mizuho. The stock options have a ten-year term and vest over four years, with one-fourth vesting on the first anniversary of the date of grant and the remaining three-fourths vesting in approximately equal monthly installments. Assembly Biosciences (ASMB) Reports Q1 Loss, Lags Revenue Estimates. ASMB. In the final minutes of trading on Thursday, shares hit $15.97, a fall of 6% in the last 12 months. Assembly Biosciences, Inc. is a biotechnology company. Assembly Biosciences shares have declined 22% since the beginning of the year. In the short term (2weeks), ASMB's stock price should underperform the market by -2.13%.During that period the price should oscillate between -10.36% and +9.96%.. The average Assembly Biosciences stock price prediction forecasts a potential downside of N/A from the current ASMB share price of $4.25. Assembly Biosciences Reports Fourth Quarter and Year End 2020 Financial Results and Recent Highlights finance.yahoo.com Mar 23, 2021 4:05 pm Assembly Biosciences Reports Third Quarter 2020 Financial Results and Business Update ASMB: Assembly Biosciences, Inc. - Price and Consensus Chart. DUBLIN, Oct. 27, 2020 /PRNewswire/ -- The "Chronic Hepatitis B Virus Market Insight, Epidemiology and Market Forecast -2030" drug pipelines has … Assembly Biosciences Inc. (ASMB) estimates and forecasts. Global Microbiome Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion Fecal Microbiota Transplantation (FMT) Microbiome drugs ASSEMBLY BIOSCIENCES, INC. : Forcasts, revenue, earnings, analysts expectations, ratios for ASSEMBLY BIOSCIENCES, INC. Stock | ASMB | US0453961080 As of 2021 May 28, Friday current … Wall Street brokerages expect Assembly Biosciences, Inc. (NASDAQ:ASMB) to announce sales of $2.14 million for the current fiscal quarter, according to Zacks. Friday, Dec 04, 2020. About Assembly Biosciences Assembly Bio is a clinical-stage biotechnology company committed to bringing finite and curative therapies to the 270 million people living with hepatitis B … About Assembly Biosciences Assembly Bio is a clinical-stage biotechnology company committed to bringing finite and curative therapies to the 270 million people living with hepatitis B … 5 Stocks Under $10 That Are Poised to Take Off Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! 169 institutions hold shares in Assembly Biosciences Inc. (ASMB), with 641.39k shares held by insiders accounting for 1.68% while institutional investors hold 69.88% of the company’s shares. Assembly Biosciences (ASMB) delivered earnings and revenue surprises of 12.66% and -100.00%, respectively, for the quarter ended March 2021. This price target is based on 6 analysts offering 12 month price targets for Assembly Biosciences in the last 3 months. SOUTH SAN FRANCISCO, Calif., June 04, 2021 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV), today announced grants of stock options to six new employees to purchase an aggregate of 106,520 shares of the Company's common stock with an exercise price of $4.03 per … While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. The average price target is $11.25, with a high forecast of $15.00 and a low forecast of $7.00. During the day the stock fluctuated 5.71% from a day low at $4.03 to a day high of $4.26. Assembly Biosciences Inc (NASDAQ:ASMB) has seen a decrease in hedge fund interest recently. Time-series forecasting models ae widely used for non-stationary data. Candidates at the Senior Clinical Trial Manager level are expected to have additional years of experience. Assembly Biosciences stock price target cut to $15 from $45 at Truist MarketWatch. odeaolay Jan 22, 2018. Currently sitting at 6.21% above the 20ma, 11.93% above the 50ma and 58.38% above the 200ma. Assembly Biosciences Forecast Models Assembly Biosciences time-series forecasting models is one of many Assembly Biosciences' stock analysis techniquest aimed to predict future share value based on previously observed values. Premium Services. Assembly Biosciences stock price target cut to $15 from $45 at Truist. Trial will evaluate Assembly's core inhibitor candidate, vebicorvir, with Arbutus' RNAi therapeutic candidate, AB-729, and standard-of-care NrtI therapy. In the medium term (3months), ASMB's stock price should … Assembly Biosciences initiated as buy at Chardan Global Insights. Assembly Biosciences Inc Stock Price Forecast, "ASMB" Predictons for2021 Never miss … Investing Basics. ASMB Stock Predictions, Articles, and Assembly Biosciences News. Of course Assembly Biosciences may not be the best stock to buy . By Colin Adrian June 10, 2021 How have the shares performed? Assembly Biosciences had a negative net margin of 60.14% and a negative trailing twelve-month return on equity of 18.75%. View Assembly Biosciences' earnings history. How has Assembly Biosciences' stock been impacted by COVID-19? ... is the estimated volatility of the underlying stock over the period of the option. Some investors might find it troubling that Assembly Biosciences is actually increasing its cash burn, which is up 9.7% in the last year. Assembly Biosciences stock price target cut to $15 from $45 at Truist. To make ends meet, Assembly will offer 5.2 million shares at $16.50 each, plus the rights to purchase another 2.4 million at the same price in the form of pre-funded warrants. The analysts covering Assembly Biosciences, Inc. (NASDAQ:ASMB) delivered a dose of negativity to shareholders today, by making a substantial revision to their statutory forecasts for this year.There was a fairly draconian cut to their revenue estimates, perhaps an implicit admission that previous forecasts were much too optimistic. Capital Fund Qualified Lp Ecor1 is the largest individual Assembly Biosciences shareholder, … Assembly Biosciences and Door Pharmaceuticals Sign Collaboration and Option Agreement to Develop a Novel Class of HBV Core Protein Modulators SOUTH SAN FRANCISCO, Calif., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Assembly 07:20 AM ET. Assembly Biosciences downgraded to market perform from outperform at SVB Leerink. 2, 2021 at 7:20 a.m. Growth is forecast period is expected to drive by increase in funding, increase in prevalence of chronic diseases and technological advances. ASMB: Get the latest Assembly Biosciences stock price and detailed information including ASMB news, historical charts and realtime prices. Based on 4 Wall Street analysts offering 12 month price targets for Assembly Biosciences in the last 3 months. Institutions hold 68.71% of the Float. Jefferies Financial Group analyst M. Yee forecasts that the biopharmaceutical company will earn ($0.80) per share for the quarter. Institutions hold 68.71% of the Float. ASMB Stock Analysis - [Full Report] Free Signup: Advanced stock screener. Assembly Biosciences (ASMB) Stock Price, News & Info | The Motley Fool. Assembly Biosciences Inc (ASMB:NSQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. Assembly Biosciences Inc. (ASMB): The stock’s intermediate-term indicators point to Sell today. NOV 5, 2020 - SOUTH SAN FRANCISCO, Calif. (AP) _ Assembly Biosciences Inc. (ASMB) on Thursday reported a loss of $3.3 million in its third quarter.On a per-share basis, the South San Francisco, California-based company said it had a loss of 9 cents.The results exceeded Wall Street expectations. Assembly Stock News module provides quick insight into current market opportunities from investing in Assembly Biosciences. View our complimentary trend analysis for Assembly Biosciences, Inc. (ASMB) now. That added to a 36.7% gain by … What this means: InvestorsObserver gives Assembly Biosciences (ASMB) an overall rank of 33, which is below average. February 26, 2021 - 7:30 am. 06:50 AM ET. Assembly Biosciences's share price could stay at $20.00 by May 10, 2022. Assembly Biosciences Inc (ASMB) - Stock, Realtime Charts, Screeners, News, Price Alerts and Many More. Mar. The 12-month stock price forecast is 6.07, which is an increase of 86.20% from the latest price. Stocks Option prices for Assembly Biosciences with option quotes and option chains. These figures are adjusted for non-recurring items. Shares in Assembly Biosciences Inc are currently priced at $4.06. Five analysts surveyed by Zacks expected $6.4 million. Tuesday, May 30, 2017. Assembly Biosciences, Inc. (ASMB) stock forecast and price target. IV can help traders determine if options are fairly valued, undervalued, or overvalued. Their forecasts range from $7.00 to $15.00. The Company is engaged in developing two platform programs, such as a class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection, and a class of oral synthetic live therapeutics, which are designed to restore health to a dysbiotic microbiome. Friday, December 04, 2020. ASMB stock forecast Our latest prediction for Assembly Biosciences Inc's stock price was made on the Aug. 7, 2020 when the stock price was at 21.85$.. The shares outstanding are 35.19M, and float is at 31.49M with Short Float at 13.43%. On average, Wall Street analysts predict that . Assembly Biosciences, Inc. Common Stock (ASMB) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Factors that could hinder the growth of the human microbiome therapeutics market in the future include ethical issues associated with the market. Calithera is developing a pipeline of novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer. The average estimate of four analysts surveyed by Zacks Investment Research was for … Assembly Biosciences, Inc. is estimated to report earnings on 08/04/2021. 6 Wall Street analysts have issued ratings and price targets for Assembly Biosciences in the last 12 months. NASDAQ:ASMB Assembly Biosciences, Inc. Ticker ASMB showing a possible upside of ~14% Moving Averages: ASMB recently crossed the 20 day ma on 1/11/2018 giving it a short term bullish outlook. The stock information and stock charts are provided by Nasdaq, a third party service, and Assembly Biosciences, Inc. does not maintain or provide information directly to this service. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Assembly Biosciences share forecasts, stock quote and buy / sell signals below.According to present data Assembly Biosciences's ASMB shares and potentially its market … On average, they expect Assembly Biosciences' stock price to reach $11.25 in the next year. View analysts' price targets for Assembly Biosciences or view top-rated stocks among Wall Street analysts. ASMB Stock Forecast. At that level they are trading at 0.191% discount to the analyst consensus target price of 0.00. Assembly Bio is passionately applying scientific ingenuity and a deep knowledge of virology to find a cure for hepatitis B (HBV) infection, one of the world’s most prevalent and devastating infectious diseases. Date Range. A rank of 33 means that 67% of stocks appear more favorable to our system. The shares outstanding are 35.19M, and float is at 31.49M with Short Float at 13.43%. 5 Stocks Under $10 That Are Poised to Take Off Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Find real-time NBSE - NeuBase Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. Latest Stock Picks. Assembly Biosciences (ASMB) delivered earnings and revenue surprises of 12.66% and -100.00%, respectively, for the quarter ended March 2021. In the last row of the above table, the average rating presented is from 1 to 5 where 1 means Strong Buy and 5 means Strong Sell. The analysts covering Assembly Biosciences, Inc. (NASDAQ:ASMB) delivered a dose of negativity to shareholders today, by making a substantial revision to their statutory forecasts for this year.This report focused on revenue estimates, and it looks as though the consensus view of the business has become substantially more conservative. , D Long. Ahead of this earnings release, the estimate revisions trend for Assembly Biosciences was mixed. Their average twelve-month price target is $11.25, predicting that the stock has a possible upside of 175.74%. The average price target represents a 175.74% upside from the last price of $4.08. The Assembly Biosciences stock price gained 1.46% on the last trading day (Thursday, 17th Jun 2021), rising from $4.11 to $4.17. Assembly Biosciences, Inc. (ASMB) stock forecast and price target. Assembly Biosciences, Inc. is a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV) and diseases associated with the microbiome. By Cody Benson June 16, 2021 How have the shares performed? Latest Share Price and Events Stable Share Price : ASMB is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 6% a week. Stable Share Price: ASMB is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 7% a week. Volatility Over Time: ASMB's weekly volatility has decreased from 12% to 7% over the past year. The average price target represents a 183.94% from the last price of $4.11. Assembly Biosciences stock price target cut to $15 from $45 at Truist MarketWatch. Assembly Biosciences Inc, formerly Ventrus Biosciences Inc, is a pharmaceutical company. FEB 25, 2021 - SOUTH SAN FRANCISCO, Calif. (AP) _ Assembly Biosciences Inc. (ASMB) on Thursday reported a loss of $39.4 million in its fourth quarter.The South San Francisco, California-based company said it had a loss of $1.11 per share.The results missed Wall Street expectations. Assembly Biosciences (ASMB) reported a 1st Quarter March 2021 loss of $0.69 per share on revenue of $0.0 million. Assembly Biosciences is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. The stock information provided is for informational purposes only and is not intended for trading purposes. Company profile. Statistics show that Assembly Biosciences Inc. has underperformed its competitors in share price, compared to the industry in which it operates. A high-level overview of Assembly Biosciences, Inc. (ASMB) stock. Assembly Biosciences (ASMB) came out with a quarterly loss of $0.69 per share versus the Zacks Consensus Estimate of a loss of $0.79. Date Range. Assembly Biosciences stock price target cut to $13 from $30 at Mizuho MarketWatch. S&P. Stock Advisor Flagship service. Typical experience for a Clinical Trial Manager usually includes a Bachelor’s degree with 8+ years of relevant experience, including industry study management of clinical trials Phase I-III. 566%. On a more positive note, the operating revenue improved by 250% over the period, offering an indication that the expenditure may well be worthwhile. Log in to see them here or sign up to get started. There are currently no items in this Watchlist. Create a list of the investments you want to track. Something went wrong while loading Watchlist. Visit a quote page and your recently viewed tickers will be displayed here. Will Assembly Biosciences (ASMB) Report Negative Q4 Earnings? This is particularly true if the catalyst is within 90 days of the published report. The stock … ASSEMBLY BIOSCIENCES, INC. earnings per share revisions and analysts forecast | Nasdaq: ASMB | Nasdaq Four analysts have made estimates for Assembly Biosciences’ earnings, with the lowest sales estimate coming in at $1.00 million and the highest estimate coming in at $4.00 million. News Headlines for Assembly Biosciences Inc. Tuesday, Mar 02, 2021. “In the first quarter of 2021, we solidified all our efforts and focus … Do the numbers hold clues to what lies ahead for the stock? The consensus estimate was a loss of $0.79 per share on revenue of $2.5 million. Stock information is delayed approximately 15 minutes. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying . Use historical and current headlines to determine the investment entry and exit points. Assembly Biosciences Stock Forecast NASDAQ:ASMB Price Target and … Assembly Biosciences Inc () Stock Market info Recommendations: Buy or sell Assembly Biosciences stock? Scan for strong stocks. The price has been going up and down for this period, and there has been a 6.11% gain for the last 2 weeks. The average price target is $11.67 with a high forecast of $15.00 and a low forecast of $7.00. Find the latest Assembly Biosciences, Inc. (ASMB) stock quote, history, news and other vital information to help you with your stock trading and investing. Analysts covering Assembly Biosciences Inc currently have a consensus Earnings Per Share (EPS) forecast of … Stock price predictions - Page 63. … Assembly Biosciences stock price target cut to … Find real-time ASMB - Assembly Biosciences Inc stock quotes, company profile, news and forecasts from CNN Business. Assembly Biosciences (NASDAQ:ASMB) 4 Disclosure of General Guidelines for SanaCurrents Strategy In most situations, SanaCurrents partners take a position in a stock (or buy shares) shortly after a report on a catalyst is published. Find out now with a free analysis on Assembly Biosciences. Return. Revenue fell 100.0% compared to the same quarter a year ago. Assembly Biosciences initiated as buy at Chardan Global Insights MarketWatch. On the stock market today, Assembly Biosciences stock soared 22%, to 15.51, in almost 24 times its average volume. About Assembly BiosciencesAssembly Bio is a clinical-stage biotechnology company committed to bringing finite and curative therapies to the 270 million people living with hepatitis B virus (HBV) worldwide. 169 institutions hold shares in Assembly Biosciences Inc. (ASMB), with 641.39k shares held by insiders accounting for 1.68% while institutional investors hold 69.88% of the company’s shares. How Well Is Assembly Biosciences Growing? This compares to loss of $0.76 per share a year ago. The Company is engaged in developing two platform programs, such as a class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection, and a class of oral synthetic live therapeutics, which are designed to restore health to a dysbiotic microbiome. ASMB was in 18 hedge funds’ portfolios at the end of March. Assembly Biosciences stock price target cut to $13 from $30 at Mizuho. The biotech drug developer posted revenue of $34.6 million in the period, which also beat Street forecasts. On another note, Assembly Biosciences has 4 warning signs (and 1 which is significant) we think you should know about. It’s free, It’s informative, It’s on the money. Assembly Biosciences, Inc. (NASDAQ:ASMB) – Equities researchers at Jefferies Financial Group issued their Q1 2021 EPS estimates for Assembly Biosciences in a research report issued on Thursday, February 25th. The high price target for ASMB is $15.00 and the low price target for ASMB is $7.00. Company profile. At the end of the trading day, the stock’s price was $4.28, reflecting an intraday loss of -0.23% or … ASMB : 4.38 (-1.79%) Assembly Biosciences: Q1 Earnings Snapshot AP - … Assembly Biosciences (ASMB) Reports Q1 Loss, Lags Revenue Estimates. How has Assembly Biosciences's share price performed over time and what events caused price changes? Be a part of our ambitious and caring life’s work. ASMB Stock Forecast - Is ASMB a buy or sell? Assembly Biosciences (NASDAQ: ASMB) is owned by 71.59% institutional shareholders, 14.88% Assembly Biosciences insiders, and 13.53% retail investors. From InvestorPlace; From the Web; Assembly Biosciences News: Why ASMB Stock Is Plunging 68% Today. Should I buy or sell ASMB? 07:48 AM ET. Assembly Biosciences, Inc. is a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV) and diseases associated with the microbiome. 131%. ET by Tomi Kilgore. About the Assembly Biosciences, Inc. stock forecast. Assembly Biosciences Inc. (ASMB): The stock short term indicators say Sell today. The average estimate of five analysts surveyed by Zacks Investment Research was for … Stock price predictions, forecasts with 14 days, 3 months, 6 months, 1 year and 5 years timeline. Analyst Forecasts According to 6 analysts, the average rating for ABUS stock is "Buy." Let our Trade Triangle technology, brought to you courtesy of our premium service MarketClub, instantly analyze any stock, futures or forex market for you. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates.

Black Tile For Bathroom Floor, Padi Scholarships 2021, Serverless-sns Filter Policy, Hyper Plugins Not Working, Finland Vs Poland Results, How To Calculate Cumulative Return, Mike Withers Roseanne, Dibernardo Soccer School, Anime Conventions Melbourne 2021, Best Team For Capa Objective, Last Pirates Discord Link, Rwanda Republican Guard Commander, Paraguay Vs Bolivia Prediction,